Hemab Therapeutics Holdings, Inc. (COAG)

Healthcare · Biotechnology · NASDAQ

Hemab Therapeutics Holdings, Inc. (COAG) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.32B and a free-cash-flow yield of -4.5%.

Market cap	$2.32B
Trailing P/E	—
FCF yield	-4.5%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live COAG data on Nama Insights →